Agneta Freijs
Impact in
-
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
- Neutropenia and Cancer Infections 1
-
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Rolf Larsson (6 shared papers)Jonas Bergh (4 shared papers)Mats O. Karlsson (6 shared papers)Marie Sandström (5 shared papers)Peter Nygren (4 shared papers)M. O. Karlsson (3 shared papers)Lena E. Friberg (2 shared papers)Valéria Molnár (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Drug Metabolism and Disposition (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwedenNetherlandsDenmark
In The Last Decade
Agneta Freijs
9 papers receiving 363 citations
Peers
Comparison fields: 5 of 67
- Oncology 203
- Pharmacology 52
- Modeling and Simulation 21
- Statistics and Probability 28
- Hematology 26
Countries citing papers authored by Agneta Freijs
This map shows the geographic impact of Agneta Freijs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Freijs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Freijs more than expected).
Fields of papers citing papers by Agneta Freijs
This network shows the impact of papers produced by Agneta Freijs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Freijs. The network helps show where Agneta Freijs may publish in the future.
Co-authors
The 18 scholars most cited alongside Agneta Freijs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 69 | |
| 2 | 2003 | 68 | |
| 3 | 2000 | 67 | |
| 4 | 1996 | 60 | |
| 5 | 1998 | 60 | |
| 6 | 2000 | 33 | |
| 7 | 1999 | 14 | |
| 8 | Haematological toxicity following different dosing schedules of 5-fluorouracil and epirubicin in rats. | 2000 | 8 |
| 9 | 2007 | 6 |
About Agneta Freijs
Agneta Freijs is a scholar working on Oncology, Pharmacology, Public Health, Environmental and Occupational Health, Hematology and Genetics, having authored 9 papers that have together received 385 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Cancer Treatment and Pharmacology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Blood disorders and treatments (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Oncology (203 citations), Pharmacology (52 citations), Modeling and Simulation (21 citations), Statistics and Probability (28 citations) and Hematology (26 citations). Agneta Freijs has collaborated with scholars based in Sweden, Netherlands and Denmark. Frequent co-authors include Rolf Larsson, Jonas Bergh, Mats O. Karlsson, Marie Sandström, Peter Nygren, M. O. Karlsson, Lena E. Friberg, Valéria Molnár, Alex Sparreboom and Anja Henningsson. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Pharmacology and Experimental Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.